alpha-glutamyltryptophan has been researched along with Benign Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anisimov, VN; Khavinson, VK; Morozov, VG | 1 |
1 other study(ies) available for alpha-glutamyltryptophan and Benign Neoplasms
| Article | Year |
|---|---|
Immunomodulatory synthetic dipeptide L-Glu-L-Trp slows down aging and inhibits spontaneous carcinogenesis in rats.
Topics: Adjuvants, Immunologic; Aging; Animals; Dipeptides; Female; Mice; Mice, Inbred CBA; Neoplasms; Peptides; Rats; Sheep; Tissue Distribution | 2000 |